top of page
Search

Gene Therapy Market Size and Share: Key Regional Developments, Leading Players, and Future Outlook 2024-2032

  • Writer: Ashish Jagtap
    Ashish Jagtap
  • Dec 27, 2024
  • 3 min read

Straits Research, a premier market research and consulting firm, has published a detailed analysis of the global gene therapy market, showcasing unprecedented growth potential. The report highlights the market’s evolution, key drivers, trends, and opportunities, offering critical insights for industry stakeholders.

Market Overview

The global gene therapy market was valued at USD 5.17 billion in 2022 and is projected to grow exponentially to USD 39.95 billion by 2031. This represents a robust compound annual growth rate (CAGR) of 25.51% during the forecast period from 2023 to 2031. These numbers underscore the transformative impact of gene therapy innovations in addressing unmet medical needs across various therapeutic areas.

For a comprehensive overview, access the full PDF sample copy of the report @ https://straitsresearch.com/report/gene-therapy-market/request-sample

Market Definition

Gene therapy is an advanced medical technique involving the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent diseases. This innovative approach is revolutionizing the treatment landscape for numerous conditions, from rare genetic disorders to prevalent diseases like cancer.

Latest Market Trends

  1. Expansion of personalized medicine driven by advancements in genomic analysis and gene-editing technologies.

  2. Rising investments in research and development for novel viral and non-viral delivery methods.

  3. Accelerated regulatory approvals for groundbreaking gene therapy products in the oncology and rare disease segments.

Key Growth Factors

  1. Increasing prevalence of genetic and chronic diseases worldwide, creating a demand for innovative treatment options.

  2. Technological advancements in vector design and gene-editing tools like CRISPR-Cas9.

  3. Supportive government policies and funding initiatives aimed at fostering gene therapy research and commercialization.

Key Market Opportunities

  1. Growing potential for gene therapies to address unmet needs in rare diseases and inherited disorders.

  2. Expanding healthcare infrastructure in emerging economies, offering a fertile ground for market penetration.

  3. Strategic partnerships between biotech firms and academic institutions to accelerate therapeutic developments.

Market Segmentation

The gene therapy market is segmented into the following categories:

By Type:

  • Gene silencing

  • Cell replacement

  • Gene augmentation

  • Other therapies

By Vector:

  • Viral vectors

  • Non-Viral vectors

By Therapeutic Area:

  • Neurology

  • Oncology

  • Hepatology

  • Other therapeutic areas

By Delivery Method:

  • In Vivo

  • Ex Vivo

By Route of Administration:

  • Intravenous

  • Other routes of administration

By Indication:

  • Cancer

  • Metabolic Disorders

  • Eye Disorders

  • Spinal Muscular Atrophy

  • Other Indications

By Technology:

  • Adeno Virus Vector

  • Adeno-associated Virus Vector

  • Lentiviral Vector

  • Retroviral Vector

  • Herpes Virus Vector

  • Other Technologies

Regional Insights

Dominated Region: North America

North America leads the gene therapy market, supported by a robust healthcare infrastructure, significant investments in research and development, and early adoption of cutting-edge technologies.

Fastest Growing Region: Asia Pacific

Asia Pacific is anticipated to witness the fastest growth during the forecast period, fueled by rising healthcare expenditure, growing awareness about gene therapies, and supportive government initiatives in countries like China and India.

Key Players

The competitive landscape of the gene therapy market is marked by the presence of leading global companies, including:

  • REGENXBIO, Inc.

  • Oxford BioMedica plc

  • Dimension Therapeutics, Inc.

  • Bristol-Myers Squibb Company

  • SANOFI

  • Applied Genetic Technologies Corporation

  • F. Hoffmann-La Roche Ltd

  • Bluebird Bio, Inc.

  • Novartis AG

  • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)

  • UniQure N.V.

  • Shire Plc

  • Cellectis S.A.

  • Sangamo Therapeutics, Inc

  • Orchard Therapeutics

  • Gilead Lifesciences, Inc.

  • BENITEC BIOPHARMA

  • Sibiono GeneTech Co., Ltd

  • Shanghai Sunway Biotech Co., Ltd.

  • Gensight Biologics S.A.

  • Transgene

  • Calimmune, Inc.

  • Epeius Biotechnologies Corp.

  • Astellas Pharma, Inc.

  • American Gene Technologies

  • BioMarin Pharmaceuticals, Inc.

Conclusion

The gene therapy market’s rapid expansion highlights its potential to revolutionize modern medicine, offering innovative solutions for previously untreatable diseases. As key regions and players continue to drive innovation and investment, gene therapy is set to become a cornerstone of advanced therapeutic strategies.

For more information, queries, or customization requests, visit: https://straitsresearch.com/buy-now/gene-therapy-market

 
 
 

Comments

bottom of page